-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Milestone Pharmaceuticals, Lowers Price Target to $5

Benzinga·11/16/2026 15:36:27
Listen to the news
TD Cowen analyst Ritu Baral maintains Milestone Pharmaceuticals (NASDAQ:MIST) with a Buy and lowers the price target from $8 to $5.